The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastomaMin Pan, Paul Geeleher, Manbir Sandhu et al.|Nature Communications|2021Cited by 95
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastomaMin Pan, Paul Geeleher, William C. Wright et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 6